Hematology & Medical Oncology Practice Updates and Board Review 2025

Kapalua, HI US
February 3, 2025 to February 7, 2025

This course offers Live (in-person) and Livestream (virtual) attendance options.

Course Director: Kebede H. Begna, M.D.

Co-Directors: Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.

February 3 - 7, 2025 - The Ritz Carlton Maui - Kapalua, Hawaii

The Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review course is designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical practice.  In addition, the high-yield program content prepares candidates for the American Board of Internal Medicine (ABIM) initial and maintenance of certification examinations in hematology and medical oncology. 

Course Highlights:

  • Comprehensive, high-yield review led by Mayo Clinic experts
  • Updates on latest guidelines and practices in the field
  • Dedicated time for questions and discussion
  • Daily optional practice sessions in board review format
  • Access to course recordings for one year

Target Audience

This course is designed for hematologists, oncologists, internal medicine physicians, NPs, PAs and other internists with interest in hematology and medical oncology.  Others that may find this course beneficial include physicians needing MOC and those preparing for certification or recertification in hematology and medical oncology.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Utilize evidence-based practice to manage patients with bleeding and/or clotting disorders
  • Choose appropriate molecular tests like next generation sequencing for cancer diagnosis
  • Integrate into practice the most current treatment options like immuno- or targeted-therapy for cancers


Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 26.25 ABIM
  • 31.25 ABS
  • 31.25 AMA PRA Category 1 Credit
  • 31.25 Attendance
Event starts: 
02/03/2025 - 6:00am
Event ends: 
02/07/2025 - 12:45pm

Schedule reflects Hawaii time zone.
PDF/Printable Version

MONDAY, February 3

5:45 a.m. – 7:00 a.m.

Registration, Breakfast & Exhibits

6:00 a.m.

Optional Breakfast Learning Session

Board Review Style Questions – Breast and GI (pre-test)

Brenda Ernst, M.D.

Thor Halfdanarson, M.D.

7:00 a.m.

Welcome Announcements – General Session

 

Breast Cancer

Moderator: Kathryn Ruddy, M.D.

7:05 a.m.

 

Early Breast Cancer – Locoregional Therapy (including surgery & radiotherapy)

Tina Hieken, M.D.

7:25 a.m.

Systemic Therapy for Her2- Positive Breast Cancer: Curative & Palliative

Pooja Advani, M.B.B.S., M.D.

8:00 a.m.

 

Systemic Therapy for Triple Negative Breast Cancer: Curative & Palliative

Roberto Leon Ferre, M.D.

8:35 a.m.

 

Systemic Therapy for ER+Her2- Breast Cancer: Curative & Palliative

Tufia Haddad, M.D.

9:10 a.m.

Panel Question and Answer Session

 

9:30 a.m.

Refreshment Break & Exhibits

 

Gastrointestinal Cancer

Moderators: Tanios Bekaii-Saab, M.D. and Thor Halfdanarson, M.D.

9:45 a.m.

 

Management of Early-stage Colorectal Cancer Including Non-Operative Management of Rectal Cancer

Jeremy Jones, M.D.

10:15 a.m.

 

Management of Advanced Colorectal Cancer

Tanios Bekaii-Saab, M.D.

10:45 a.m.

 

Upper GI & other GI Cancers

Bassam Sonbol, M.D.

11:15 a.m.

 

Management of Hepatobiliary Cancers

Mitesh Borad, M.D.

11:45 a.m.

 

Management of Pancreatic Cancer

Robert McWilliams, M.D.

12:15 p.m.

 

Panel Question and Answer Session

 

12:35 p.m.

Adjourn

 

TUESDAY, February 4

5:45 a.m. – 7:00 a.m.

Breakfast & Exhibits

6:00 a.m.

 

Optional Breakfast Learning Session

Board Review Style Questions – Lung, Head and Neck and Neuro / GU Cancers and Sarcoma

Rami Manochakian, M.D.

Dan Childs, M.D.

7:00 a.m.

Welcome Announcements – General Session

 

Lung, other Thoracic, Head & Neck Cancer, Neuro-Oncology

Moderator: Rami Manochakian, M.D.

7:05 a.m.

 

Early Stage NSCLC

Vinicius Ernani, M.D.

7:35 a.m.

 

Advanced Stage NSCLC

Rami Manochakian, M.D.

8:10 a.m.

 

Small Cell Lung Cancer

Kaushal Parikh, M.B.B.S.

8:35 a.m.

 

Other Thoracic Malignancies (mesothelioma, thymic, neuroendocrine)

Kostas Leventakos, M.D., Ph.D.

9:00 a.m.

 

Panel Question and Answer Session

 

9:10 a.m.

Refreshment Break & Exhibits

 

9:20 a.m.

 

Head and Neck Cancer

Katharine Price, M.D.

Daniel Price, M.D.

9:50 a.m.

 

Neuro-Oncology

Alyx Porter, M.D.

10:10 a.m.

 

Sarcoma

Steve Robinson, M.B.B.S.

10:30 a.m.

 

Panel Question and Answer Session

 

10:40 a.m.

Refreshment Break & Exhibits

 

Genitourinary Cancer

Moderator: Thor Halfdanarson, M.D.

10:50 a.m.

 

Bladder / Urothelial Cancer

Parminder Singh, M.D.

11:20 a.m.

 

Renal Cell Carcinoma

Yousef Zakharia

11:50 a.m.

 

Germ Cell Cancers

Lance Pagliaro, M.D.

12:10 a.m.

 

Prostate Cancer

Dan Childs, M.D.

12:45 p.m.

 

Panel Question and Answer Session

 

12:55 p.m.

Adjourn

 

WEDNESDAY, February 5

5:45 a.m. – 7:00 a.m.

Breakfast & Exhibits

6:00 a.m.

 

Optional Breakfast Learning Session

Board Review Style Questions – Gyn & Other Cancers / Miscellaneous

Andrea Wahner-Hendrickson, M.D.

Ryan Carr, M.D., Ph.D.

7:00 a.m.

Welcome Announcements – General Session

 

Gynecologic and Other Cancers

Moderator: Kathryn Ruddy, M.D.

7:05 a.m.

 

Ovarian Cancer

Andrea Wahner-Hendrickson, M.D.

7:45 a.m.

 

Cancers of the Cervix, Uterus and Other Less Common GYN Cancers

John Weroha, M.D., Ph.D.

8:20 a.m.

 

Melanoma

Svetomir Markovic, M.D., Ph.D.

8:45 a.m.

 

Endocrine Oncology (thyroid, adrenals)

Mabel Ryder, M.D.

9:10 a.m.

 

Panel Question and Answer Session

 

9:20 a.m.

Refreshment Break & Exhibits

 

Miscellaneous

Moderators: Kebede Begna, M.D. and Thor Halfdanrson, M.D.

9:30 a.m.

 

Genomics for Hematologist/Medical Oncologist

Ryan Carr, M.D., Ph.D.

10:00 a.m.

 

Hereditary Syndromes (when to refer to clinical genomics, germline testing, etc.)

Siddhartha Yadav, M.B.B.S., M.D.

10:25 a.m.

 

Transfusion Medicine for Hematologist/Medical Oncologist

Jeffrey Winters, M.D.

10:50 a.m.

 

Panel Question and Answer Session

 

11:00 a.m.

Refreshment Break & Exhibits

 

11:10 a.m.

 

Management of Thrombosis in Cancer

Aneel Ashrani, M.D., M.S.

11:35 a.m.

 

Palliative Care and Symptom Management

Jacob Strand, M.D.

12:00 p.m.

 

Cancer Survivorship: Crafting a Blueprint for the Future of Assessing/Managing Complications, cardio-, neuro-, renal- toxicity, etc.

Carrie Thompson, M.D.

12:25 p.m.

 

Panel Question and Answer Session

 

12:35 p.m.

Adjourn

 

THURSDAY, February 6

5:45 a.m. – 7:00 a.m.

Breakfast & Exhibits

6:00 a.m.

 

Optional Breakfast Learning Session

Board Review Style Questions – Lymphoid Malignancies / Dysproteinemia

Jonas Paludo, M.D.                                     Ricardo Parrondo, M.D.

Muhamad Alhaj-Moustafa, M.D., M.S.      Erin Wiedmeier-Nutor, M.D., M.P.H.

7:00 a.m.

Welcome Announcements – General Session

 

Lymphoid Malignancies

Moderators: Sameer Parikh, M.B.B.S.

7:05 a.m.

 

Hodgkin Lymphoma

Stephen Ansell, M.D., Ph.D.

7:25 a.m.

 

Aggressive B Cell Lymphoma

Grzegorz Nowakowski, M.D.

7:50 a.m.

 

CLL

Sameer Parikh, M.B.B.S.

8:15 a.m.

 

Follicular Lymphoma and Mantle Cell Lymphoma

Thomas Witzig, M.D.

8:40 a.m.

 

Other Indolent non-Hodgkin Lymphoma

Thomas Habermann, M.D.

9:05 a.m.

 

T Cell Lymphoma

Allison Rosenthal, D.O.

9:25 a.m.

 

Panel Question and Answer Session

 

9:40 a.m.

Refreshment Break & Exhibits

 

Dysproteinemia

Moderator: Wilson Gonsalves, M.D.

9:55 a.m.

 

MGUS / Smoldering Myeloma

Angela Dispenzieri, M.D.

10:20 a.m.

 

Newly Diagnosed Multiple Myeloma

Vivek Roy, M.D.

10:50 a.m.

 

Relapsed / Refractory Multiple Myeloma

Rafael Fonseca, M.D.

11:20 a.m.

 

Cellular Therapy for Hematological Malignancies

Yi Lin, M.D., Ph.D.

11:50 a.m.

 

Waldenstrom Macroglobulinemia and Amyloidosis

Morie Gertz, M.D.

12:15 p.m.

 

Panel Question and Answer Session

 

12:30 p.m.

Adjourn

 

FRIDAY, February 7

5:45 a.m. – 7:00 a.m.

Breakfast & Exhibits

6:00 a.m.

 

Optional Breakfast Learning Session

Board Review Style Questions – Myeloid Neoplasms / Classic Hematology

Lisa Sproat, M.D.                                   Meera Sridharan, M.D., Ph.D.

Abhishek Mangaonkar, M.B.B.S.          Surbhi Shah, M.B.B.S.

7:00 a.m.

Welcome Announcements – General Session

 

Myeloid Neoplasms

Moderators: Kebede Begna, M.D. and Naseema Gangat, M.B.B.S.

7:05 a.m.

 

MPN and CML

Ayalew Tefferi, M.D.

7:35 a.m.

 

BMF Syndromes: CCUS/ICUS/MDS/AA

Mrinal Patnaik, M.B.B.S.

8:05 a.m.

 

Mast Cell & Eosinophilic Neoplasms

Animesh Pardanani, M.B.B.S., M.D.

8:25 a.m.

 

Acute Myeloid Leukemia

Naseema Gangat, M.B.B.S.

8:55 a.m.

 

Acute Lymphoblastic Leukemia

Mark Litzow, M.D.

9:25 a.m.

 

Transplantation for Hematological Disorders including GVHD

William Hogan, M.B., B.Ch.

9:55 a.m.

 

Panel Question and Answer Session

 

10:05 a.m.

Refreshment Break & Exhibits

 

Consultative & Classical Hematology

Moderators: Ronald Go, M.D. and Surbhi Shah, M.B.B.S.

10:15 a.m.

 

Thrombotic Microangiopathy / HLH & Porphyrias

Alexandra Wolanskyi-Spinner, M.D.

10:40 a.m.

 

Platelet & Megakaryocyte Disorders

Meera Sridharan, M.D., Ph.D.

11:05 a.m.

 

Coagulation Factors Disorder: Molecular Basis, Inherited and Acquired Bleeding Disorders

Rajiv Pruthi, M.B.B.S.

11:25 a.m.

 

Sickle Cell Disease, Thalassemia & Other Hemoglobinopathies

Ewa Wysokinska, M.D.

11:50 a.m.

 

Anemia / Iron Metabolism Disorders

Ronald Go, M.D.

 

12:15 p.m.

 

Hemolytic Anemias including PNH

Surbhi Shah, M.B.B.S.

 

 

12:40 p.m.

 

Panel Question and Answer Session

 

12:50 p.m.

Adjourn

 

The Ritz Carlton Maui, Kapalua
1 Ritz-Carlton Dr.
Kapalua, HI 96761
United States

 

 

 

 

 

 

 

Lodging

Rooms have been reserved for attendees and their guests at the Ritz Carlton for discounted rates starting at $449/night.  In order to receive the special rates, reservations must be made before January 6, 2025, or before the room block fills.

Room reservations after are based on space and rate availability.  Additional taxes will apply.  Valet and self-parking options are available for additional fees. 

  • Deluxe resort view:  $449/night
  • Deluxe ocean view:  $489/night

Click here to make reservation online (select resort or ocean view) or call 800-262-8440 and identify yourself as a participant of the 2025 Hematology/Oncology Board Review when making reservations.

Daily Resort Fee ($20):

The daily resort fee $40 is discounted at a rate of $20 per room per night for all attendees staying at the resort.  The fee includes the following:

  • Enhanced high-speed guest room Wi-Fi
  • Kapalua Resort Shuttle Services (travel within Kapalua Resort)
  • Aloha welcome experience with non-alcoholic beverage delighter and fresh flower or kukui nut lei
  • Discounted golf fees & preferred tee times at Kapalua Plantation & Bay courses
  • 24-hour fitness center access
  • in-room coffee & complimentary bottled water
  • Resort activities (basketball, tennis & pickleball, shuffleboard, croquet)
  • Signature daily experiences including guided labyrinth mediation walk, sunrise yoga, etc. (offerings change seasonally)

Travel

All travel and lodging expenses are the sole responsibility of the individual registrant.  Mayo Clinic School of Continuous Professional Development is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting.  Costs incurred by the registration such as airline or hotel fees or penalties are the responsibility of the registrant. 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 26.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 26.25 ABIM
  • 31.25 ABS
  • 31.25 AMA PRA Category 1 Credit
  • 31.25 Attendance

Exhibit & Sponsorship Opportunities Available!

The Hematology & Medical Oncology Practice Updates and Board Review 2025 course is pleased to offer the opportunity for commercial companies to interact with health care providers and highlight their products and services.  If you are interested in exhibiting or sponsoring the course, please complete the following:

 
Status
Price
Title
$1,450.00Included
Please login or register to take this course.
$1,450.00Included
Please login or register to take this course.
Please login or register to take this course.

Please update your profile to let us know if you have dietary restrictions or access requirements. 


To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery.


Commitment to Equity, Diversity and Inclusion​ 

Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.  ​ 


Cancellation and Refund Policy

View Cancellation and Refund Policy

All requests must be submitted in writing using the Contact Us Form.

Any use of this site constitutes your agreement to the Terms and Conditions of Registration.